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The biosynthesis of norepinephrine occurs through a multi-enzymatic pathway that
includes the enzyme dopamine-β-hydroxylase (DBH). Mice with a homozygous deletion of
DBH (Dbh−/−) have a selective and complete absence of norepinephrine. The purpose of this
study was to assess the expression of alpha-1, alpha-2 and beta adrenergic receptors (α1-AR,
α2-AR and β-AR) in the postnatal absence of norepinephrine by comparing noradrenergic
receptors in Dbh−/− mice with those in Dbh heterozygotes (Dbh+/−), which have normal
levels of norepinephrine throughout life. The densities of α1-AR, α2-AR and β-AR were
assayed with [3H]prazosin, [3H]RX21002 and [125I]-iodo-pindolol autoradiography,
respectively. The α2-AR agonist high affinity state was examined with [125I]-para-
iodoclonidine autoradiography and α2-AR functionality by α2-AR agonist-stimulated [35S]
GTPγS autoradiography. The density of α1-AR in Dbh−/−mice was similar to Dbh+/−mice in
most brain regions, with an up-regulation in the hippocampus. Modest decreases in α2-AR
were found in septum, hippocampus and amygdala, but these were not reflected in α2-AR
functionality. The density of β-AR was up-regulated to varying degrees in many brain
regions of Dbh−/− mice compared to the heterozygotes. These findings indicate that
regulation of noradrenergic receptors by endogenous norepinephrine depends on receptor
type and neuroanatomical region.
© 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Norepinephrine is a neurotransmitter that signals through alpha-
1, alpha-2 and beta adrenergic receptors (α1-AR, α2-AR and β-AR)
(Bylund et al., 1994). These are G-protein-coupled receptorswhose
signaling is important for the regulation of diverse processes
within themature and developing brain (Morris et al., 1983; Lau et
al., 1990; Nutt et al., 1997; Troadec et al., 2001). Recently,
investigation of noradrenergic regulation of CNS function has
been facilitated by the development of mice with a genomic
deletionofdopamine-β-hydroxylase (DBH), theenzymenecessary
for conversion of dopamine to norepinephrine (Thomas et al.,
1995). Mice with a homozygous deletion of DBH (Dbh−/−) have a
selective and complete absence of norepinephrine throughout
postnatal development and into adulthood, whereas heterozy-
gotes (Dbh+/−) have normal central norepinephrine levels (Tho-
mas et al., 1995, 1998; Bourdelat-Parks et al., 2005). Prenatally
adrenergic agonistsaswell as thenorepinephrineprecursor, L-3,4-
dihydroxyphenylserine, are provided to pregnant dams via
drinking water to assure survival of the Dbh−/−mice (Thomas et
al., 1995).
Behaviorally, Dbh−/− mice manifest a variety of anomalies
that point to the importance of norepinephrine in brain
function. These include deficits in active-avoidance learning
(Thomas and Palmiter, 1997), a failure to respond to anti-
depressants (Cryan et al., 2004), a sensitization to ampheta-
mine (Weinshenker et al., 2002b) and an increased suscept-
ibility to seizure-inducing stimuli (Szot et al., 1999). Despite
the in-depth characterization of behavior in Dbh−/−mice, little
is known about the effects of this deletion on noradrenergic
receptor expression, the natural target of norepinephrine. This
information will be helpful in interpreting the differing
responses of Dbh+/− and Dbh−/−mice to noradrenergic agents
and it will provide data relevant to the role of norepinephrine
in regulating the developmental expression of noradrenergic
receptors in the postnatal period. In the current studies, we
examined differences in the expression of α1-AR, α2-AR and β-
AR within the brains of the Dbh+/− and Dbh−/− genotypes, a
model of specific and non-traumatic norepinephrine elimina-
tion throughout postnatal development and into adulthood
(Thomas et al., 1995).
2. Results
2.1. [3H]RX821002 autoradiography
The highest densities of α2-AR in adultmouse CNSwere found
in septum and amygdala, with lower densities throughout the
cortex and hippocampus, based on [3H]RX821002 autoradio-
graphy (Fig. 1A). Hippocampal α2-AR were most highly
expressed in the stratum lacunosum-moleculare (slm) with
near undetectable levels in other hippocampal regions (Fig.
1A). InDbh−/−mice α2-ARwere very similar in density to those
found in Dbh+/− mice in the cerebral cortex, based on ligand
binding, but there was a small but statistically significant
decrease in receptor density in the septum and amygdala
(both decreased ∼15%; Figs. 1A and B). The greatest difference
between heterozygous and homozygous mice was found in
the hippocampus (slm), where there was a 35% decrease in
receptor density in Dbh−/− mice compared to heterozygotes
(Figs. 1A and B).
Fig. 1 – α2-Adrenergic receptor densities in CNS regions of
Dbh+/− and Dbh−/− mice. (A) Representative bright field
autoradiographs of total [3H]RX821002 binding in Dbh+/− and
Dbh−/−mouse brain. Non-specific binding was 10% or less of
total binding and was frequently not detectable. Inserts:
higher magnification of [3H]RX821002 binding. Decreases in
α2-AR are found within septum, hippocampus (slm: black
arrows) and amygdala of Dbh−/− mice. (B) Quantification of
[3H]RX821002 binding within Dbh+/− and Dbh−/− mouse
brain. Dbh−/− mice display a significant reduction in [3H]
RX821002 binding within the septum, hippocampus (slm)
and amygdala compared to heterozygotes. CTX=cortex;
SEP=septum; HIP=hippocampus; AMY=amygdala. Data are
mean±SEM; n=4 for each genotype. *p<0.05, **p<0.01:
two-tailed t test comparing binding in neuroanatomical
regions of Dbh+/− vs. Dbh−/− mice.
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2.2. [125I]-p-Iodoclonidine autoradiography
We further investigated potential differences in the α2-AR by
examining the agonist high affinity state of the receptor, the
active formof the receptor directly linked to G proteins. For these
studies we used [125I]PIC, a radioligand that selectively binds to
the agonist high affinity state of α2-AR when used at very low
concentrations, as in theseassays. Similar toour findings for total
α2-AR with [3H]RX821002, [125I]PIC binding was highest in the
amygdala and septum of Dbh+/− and Dbh−/− mice, with lower
levels throughout thecortexandhippocampus (slm) (Figs. 2Aand
B). The agonist high-affinity state of the α2-AR changed very little
when norepinephrine was absent. A small, but statistically
significant decrease in receptor density was seen only within
the septum (∼20%; Fig. 2B).
2.3. α2-AR agonist-stimulated [35S]GTPγS incorporation
Because surprisingly few changes were found in Dbh−/−
animals in total α2-AR density or in percentage of receptors
in the agonist high affinity state, we examined α2-AR agonist-
stimulated [35S]GTPγS binding to determine if there was a
change in receptor linkage to G proteins, the next step in the
signal transduction pathway for α2-AR. Dbh+/− and Dbh−/−
mice were similar in basal [35S]GTPγS binding across brain
regions and had a similar level of [35S]GTPγS incorporation in
response to epinephrine stimulation (Figs. 3A and B). For both
Dbh+/− and Dbh−/− mice, stimulation of [35S]GTPγS binding
following α2-AR stimulation was ∼75% above basal for frontal
cortex, ∼140% for septum and ∼30% for hippocampus and
amygdala (Figs. 3A and B). The α2-AR antagonist, RX821002
(10 μM), alone did not affect basal activity in any brain region
but did block the ability of epinephrine to stimulate [35S]GTPγS
binding (Fig. 3B), indicating this was an α2-AR-specific effect.
The similarity in epinephrine-induced [35S]GTPγS incorpora-
tion between both groups of mice indicates that sensitization
of α2-AR signal transduction mechanisms, at least at the level
of G protein coupling, does not occur in the absence of
norepinephrine postnatally.
2.4. [3H]Prazosin autoradiography
Given the relatively minor changes in α2-AR density in animals
lacking norepinephrine throughout postnatal development, we
examined other adrenergic receptors to determine whether the
inability to synthesize norepinephrinewould affect their develop-
ment. α1-AR binding sites were found in greatest quantity in the
dorsal raphe with moderate levels in the cerebral cortex, bed
nucleus of the stria terminalis and thalamus and lowest level in
the septum and hippocampus (Figs. 4A and B). [3H]Prazosin α1-AR
binding sites inDbh−/−mice didnot differ in density from those in
Dbh+/− mice in any region except the hippocampus, where a
significant increase (∼75%) inbindingsiteswasobserved inDbh−/−
mice (Figs. 4A and B).
2.5. [125I]Pindolol autoradiography
We also examined β-AR in Dbh−/− mice. Expression of β-AR
was highest in cortex with lower levels in septum and
hippocampus. In contrast to the alpha adrenergic receptors,
β-AR exhibited a significant up-regulation in all brain regions
examined. In the cortex and septum, β-AR were significantly
increased ∼30% over Dbh+/− mice, whereas the density of
these receptors in the hippocampus was increased by ∼50%
(Figs. 5A and B).
3. Discussion
Many studies have suggested that norepinephrine can play an
important role in regulating development of the CNS (Felten et
al., 1982; Blue and Parnavelas, 1982; Parnavelas and Blue,
1982). This regulation would be coordinated via norepine-
phrine's signaling through α1-AR, α2-AR and β-AR (Bylund et
al., 1994). Each of these receptors has at least three subtypes
and the subtypes possess distinct pharmacological profiles
Fig. 2 – α2-Adrenergic receptor agonist high-affinity state
densities in CNS regions of Dbh+/− and Dbh−/−mice. (A)
Representative bright field autoradiographs of total
[125I]-p-iodoclonidine binding in Dbh+/− and−/−mouse brain.
Non-specific bindingwas less than15%of total bindingandwas
evenly distributed. (B) Quantification of [125I]-p-iodoclonidine
binding within Dbh+/− and Dbh−/−mouse brain. There is a
significant reduction in [125I]-p-iodoclonidinebindingwithin the
septum of Dbh−/−mice compared to Dbh+/−mice. CTX=cortex;
SEP=septum; HIP=hippocampus; AMY=amygdala. Data are
mean±SEM; n=4 for each genotype. **p<0.01: two-tailed t test
comparing binding in neuroanatomical regions of Dbh+/− vs.
Dbh−/−mice.
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Fig. 3 – α2-Adrenergic receptor-stimulated [35S]GTPγS autoradiography in CNS regions of Dbh+/− and Dbh−/− mice. (A)
Representative bright field autoradiographs of total [3H]RX821002 binding (right and left complete sections: [3H]RX-AR) and
epinephrine-stimulated [35S]GTPγS binding within coronal sections (middle inset) of Dbh+/− and Dbh−/− mice. (B)
Quantification of epinephrine-stimulated [35S]GTPγS binding in Dbh+/− and Dbh−/−mice. Despite the developmental absence
of norepinephrine in Dbh−/− mice, epinephrine-stimulated [35S]GTPγS binding is similar between Dbh−/− and Dbh+/− mice.
EPI=epinephrine (100 μM), RX=RX821002 (10 μM). Data are mean±SEM; n=4 for each genotype. ***p<0.001 compared with
basal; ###p < 0.001 compared to EPI: one-way ANOVA followed by Tukey multiple comparison post hoc test.
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and differential distributions within the central nervous
system (Bylund et al., 1994) (Zhong and Minneman, 1999,
7388/id; Nicholas et al., 1996, 5798/id;McCune et al., 1993, 5413/
id; Rainbow et al., 1984, 6706/id). There are also changes in
adrenergic receptor distribution during development, but few
have examined receptor subtypes (Jones et al., 1985; Goffinet
et al., 1986; Winzer-Serhan and Leslie, 1997; Winzer-Serhan et
al., 1997a,b; Happe et al., 2004).
Because adrenergic receptors are the physiological target of
norepinephrine, it is reasonable to expect that loss of
norepinephrine during postnatal development would lead to
changes in these receptors.We examined this possibility using
mice lacking DBH, the final enzymatic step in the synthetic
pathway for norepinephrine. Although it is necessary for the
survival of Dbh−/− embryos to provide adrenergic receptor
stimulation prenatally by providing receptor agonists and
DOPS in the drinking water of pregnant dams (see Experi-
mental procedures), these mice completely lack norepineph-
rine from birth forward (Thomas et al., 1995). In these studies,
we compared the Dbh−/− mice to Dbh+/− mice, which have
been shown to have normal central levels of norepinephrine
(Thomas et al., 1995, 1998; Bourdelat-Parks et al., 2005). These
animals also have normal localization and density of nora-
drenergic terminals as indicated by the distribution and
density of the norepinephrine transporter (Weinshenker et
al., 2002b), a highly specific marker for norepinephrine
neurons. This indicates the changes found cannot be ascribed
to changes in distribution of noradrenergic terminals.
We found that the postnatal absence of norepinephrine
yields differing effects depending on noradrenergic receptor
type and brain region. The density of α1-AR, indicated by [3H]
prazosin bindingwas similar betweenDbh+/− andDbh−/−mice
except for a significant increase in hippocampus in Dbh−/−
mice, in contrast to α2-AR. The density changes in α2-AR,
determined by [3H]RX821002 binding, also were relatively
minor in the absence of norepinephrine. There were small
decreases in α2-AR density in septum, hippocampus (slm) and
amygdala. However, the agonist high-affinity state of α2-AR,
examinedwith [125I]PIC binding,was decreased only in septum
and the functional linkage of these receptors, measured by
agonist-stimulated [35S]GTPγS binding, was not significantly
altered in any brain region examined. These data suggest that
the number of α2-AR linked to G proteins remained relatively
constant in all brain regions, even though there were small
changes in total α2-AR density. In contrast to α1-AR and α2-AR,
Dbh−/− mice respond to the developmental absence of
norepinephrine by increasing β-AR expression throughout
the brain, with 30% increases in cortex and septum and a 50%
increase in hippocampus.
It is important to note that because DBH catalyzes the
conversion of dopamine to norepinephrine, Dbh−/− mice
produce and probably release dopamine from their noradre-
nergic terminals. Therefore, it is possible that dopamine is
providing sufficient agonist activity in Dbh−/− mice to main-
tain normal α1- and α2-AR levels. For example, some α2-AR
subtypes have an affinity for dopamine that is comparable to
their affinity for norepinephrine (Zhang et al., 1999). In
addition, the “ectopic” dopamine in Dbh−/− mice appears to
help maintain normal expression of the norepinephrine
transporter (Weinshenker et al., 2002b). However, a functional
replacement of norepinephrine by dopamine in Dbh−/− mice
is unlikely to explain themaintenance of α2-AR levels for three
reasons. First, when the selective noradrenergic neurotoxin,
N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) was
used to lesion central noradrenergic neurons in neonatal
rats, there was no “ectopic” dopamine and no change in α2-AR
density (Sanders et al., 2001) Second, Dbh−/− mice have
phenotypes (e.g., seizure susceptibility) that are reversed by
α2 agonists (Szot et al., 2004), which would not be expected if
endogenous dopamine could bind to and activate α2-AR.
Finally, locus coeruleus neurons from Dbh−/−mice completely
lack the characteristic α2-AR-mediated autoinhibition
observed in locus coeruleus neurons from normal mice,
indicating that endogenously released dopamine does not
activate α2-AR in locus caeruleus of Dbh−/− mice (C. Paladini
Fig. 4 – α1-Adrenergic receptor densities in CNS regions of
Dbh+/− and Dbh−/−mice. (A) Representative bright field
autoradiographs of total [3H]prazosin binding in Dbh+/− and
Dbh−/−mouse brain. Non-specific binding was 10% or less of
total binding and was frequently not detectable.
(B) Quantification of [3H]prazosin binding within Dbh+/− and
Dbh−/−mouse brain. Dbh−/−mice display a significant
increase in [3H]prazosin binding only in the hippocampus
when compared to Dbh+/−mice. BNST=bed nucleus of the
stria terminalis; DR=dorsal raphe. Data are mean±SEM; n=8
for each genotype. *p<0.05: two-tailed t test comparing
binding in neuroanatomical regions of Dbh+/− vs. Dbh−/−
mice.
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and D.Weinshenker, unpublished observation). The affinity of
α1-AR and β-AR for dopamine is much lower than for that of
norepinephrine, making modulation of these receptors by
dopamine highly unlikely (Zhang et al., 2004).
Previous studies have investigated the role of norepinephrine
inα1-AR,α2-AR andβ-ARontogenyby lesioning thenoradrenergic
fibers of neonatal rats with 6-hydroxydopamine (6-OHDA). One
study found a ∼20% increase in adult α1-AR and α2-AR in cortical
membranes (Dausse et al., 1982) and a separate study showed a
dramatic increase in adult β-AR (Lorton et al., 1988). These studies
have similarities and differenceswith our studies. These previous
studies found that a neonatal 6-OHDA lesion of noradrenergic
neurons lead to a detectable increase in α1-AR and α2-AR within
the cortex of mature rat brain, in contrast to our findings of no
change inmouse brain. Thismay reflect species differences or the
effects of the 10–15% of normal norepinephrine remaining
following the lesions. Similar to what is found in Dbh−/− mice,
neonatal 6-OHDA caused a persistent up-regulation of β-AR
(Lorton et al., 1988). The general pattern of β-AR up-regulation
being greater than the effects on α1-AR and α2-AR is consistent
between neonatal 6-OHDA lesion studies in rats and the Dbh−/−
mouse model.
These data from developing brain are in contrast to
noradrenergic receptor regulation in the adult brain. In adult
animals, a persistent increase in the α2-AR high affinity state
is elicited as a result of DSP-4 lesion or reserpinization, as
measured by [3H]clonidine binding to membrane preparations
(Dooley et al., 1983; Ribas et al., 2001). It is generally found that
adult noradrenergic lesions lead to moderate increases in β-
AR density (Dooley et al., 1983; Zahniser et al., 1986). In
contrast, we find a decrease or no change in total α2-AR
number, high affinity state or linkage to G proteins following a
developmental loss of norepinephrine. We and others have
found a persistent increase in β-AR (Lorton et al., 1988)
subsequent to a developmental deficiency in norepinephrine,
in contrast to the transient increases found in DSP-4 lesioned
adults. These findings indicate there are distinct differences in
adrenergic receptor regulation in CNS during postnatal devel-
opment compared to adult brain.
The profile of adrenergic receptor changes in Dbh−/− mice
differs from changes seen in mice with a homozygous
deletion of the norepinephrine transporter (Net−/−) (Gilsbach
et al., 2006; Dziedzicka-Wasylewska et al., 2006). Because
NET functions to remove released norepinephrine from the
synapse, Net−/− mice display elevated extracellular concen-
trations of norepinephrine (Vizi et al., 2004). Therefore,
Net−/− mice serve as a model of high noradrenergic tone
that differs from the Dbh−/− mouse model of loss of
noradrenergic tone. Adrenergic receptors in Net−/− mice
respond to elevated norepinephrine with decreases in α1-AR
and β-AR and accompanying increases in α2-ARA and α2-ARC
subtypes (Gilsbach et al., 2006). These changes are in the
opposite direction to the elevated α1-AR and β-AR and
decreased α2-AR we have detected in Dbh−/− mice. Taken
together, these data suggest that α1-AR, α2-AR and β-AR may
respond in an integrated and predictable way to variations
in postnatal noradrenergic tone.
The relatively small changes inα1-AR andα2-AR are consistent
with the ability of exogenous adrenergic receptor agonists to
modulate neuronal excitability and behavior inDbh−/−mice (Szot
et al., 1999;Weinshenker et al., 2001; Murchison et al., 2004). They
contrast with the significant changes found in the dopamine
system in Dbh−/− mice. Dbh−/− mice are hypersensitive to the
behavioral effects of D2 agonists and exhibit large increases in the
highaffinitystateofbrainD1andD2receptors (Weinshenkeretal.,
2002a; Schank et al., 2005). Our data indicate that α1-AR and α2-AR
arenormal in thepostnatal absence ofnorepinephrineand thatβ-
AR expression responds normally to the lack of norepinephrine,
whereas other neurotransmitter systems, such as the dopamine
system, require norepinephrine for normal development and
maintenance.
4. Experimental procedures
[3H]RX821002 (58 Ci/mmol) was obtained from Amersham
(Arlington Heights, IL). Rauwolscine, isoproterenol, epinephr-
ine bitartrate, RX821002, phentolamine, glycylglycine HCl and
dithiothreitol (DTT) were purchased from Sigma-Aldrich (St.
Fig. 5 – β-Adrenergic receptor densities in CNS regions of
Dbh+/− and Dbh−/− mice. (A) Representative bright field
autoradiographs of total [125I]pindolol binding within
horizontal sections Dbh+/− and Dbh−/− mice.
(B) Quantification of [125I]pindolol binding within Dbh+/−
and Dbh−/− mouse brain. In contrast to α1-AR and α2-AR,
β-AR sites are increased in multiple brain regions of
Dbh−/− mice. CTX=cortex, HIP = hippocampus, SEP=
septum. Data are mean±SEM; n=4 for each genotype.
***p < 0.001: two-tailed t test comparing binding in
neuroanatomical regions of Dbh+/− vs. Dbh−/− mice.
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Louis, MO.) [35S]GTPγS (1000–1500 Ci/mmol), p-[125I]iodocloni-
dine (2200 Ci/mmol), [125I]-iodo-pindolol (2200 Ci/mmol) and
[3H]prazosin (80.5 Ci/mmol) were purchased fromPerkin Elmer
(Boston, MA). Guanosine 5′-diphosphate sodium (GDP) was
purchased fromUnited States Biochemical (Cleveland, OH). All
other chemicals were research grade.
4.1. Animals
Dbh−/− and Dbh+/−mice, maintained on amixed C57BL6/J and
129SvEv background, were bred as previously described
(Thomas et al., 1995). Because Dbh−/− embryos die in mid-
gestation without norepinephrine, adrenergic agonists (phe-
nylephrine and isoproterenol) and the norepinephrine pre-
cursor L-3,4-dihydroxyphenylserine (DOPS) were supplied to
the embryos via the drinkingwater of pregnant dams (Thomas
et al., 1995). Once Dbh−/−mice are born, they no longer require
pharmacological intervention for viability or development.
Thus, the Dbh−/−mice used in this study lacked norepinephr-
ine from birth and developed postnatally in the complete
absence of norepinephrine. Mice were maintained on a 12-h
light/dark cycle in a specific pathogen-free facility at the
University of Washington (Seattle, WA), and all procedures
involving live animals were carried out in this facility. Food
andwater were available ad libitum. Adult (5–6months in age)
male and female mice were used for all experiments except
those involving α1-AR, for which all animals were 30 days old.
At 30 days of age, these mice are capable of reproduction and
their brains are mature by most measurements. Homozygotes
and heterozygotes were age-matched and all animals were
pairedwith littermates. Animalswere sacrificed by CO2, brains
rapidly removed and frozen on dry ice. All animal care
procedures were in strict accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals and were approved by the local Animal Care
Committee. All studies on α1-adrenergic receptors were
carried out at the University of Washington. All other studies
were carried out at the University of Nebraska Medical Center.
Each set of experiments was carried out on a separate group of
animals.
4.2. [3H]RX821002 autoradiography
Autoradiographic studies of α2-AR used procedures as
previously described (Happe et al., 2004). Briefly, tissue
sections 16 μm thick were thaw-mounted onto Superfrost
Plus slides (Fisher Scientific, Pittsburgh, PA) and stored at
−80 °C. Prior to use, sections were allowed to come to room
temperature for 1 h and then were incubated for 1 h at room
temperature in 50 mM sodium phosphate buffer, pH 7.4,
containing 2.0 nM [3H]RX821002. Non-specific binding was
determined by the inclusion of 10 μM rauwolscine. All
incubations except those using [3H]prazosin were carried
out in plastic slide mailers with 5 slides/9 ml incubation
buffer. Slides were washed 2×5 min in 50 ml ice-cold buffer,
briefly dipped in ice-cold distilled water to remove salts,
dried and apposed to tritium sensitive film (Hyperfilm-3H,
Amersham) for four weeks. Films were developed by
standard procedures and resulting images were analyzed
with the MCID image analysis system (Imaging Research,
Inc., St. Catherines, Ontario, Canada). Autoradiographic
densities were quantified using commercial tritium stan-
dards (ART-123; American Radiochemicals, St. Louis, MO),
which had been calibrated in this lab to tissue standards
(Geary et al., 1985). Neuroanatomy for all studies was
assessed by comparing sections to a mouse brain atlas and
coronal sections from bregma 0.98 mm to bregma −2.54 mm
were analyzed (Franklin and Paxinos, 1997). All data for each
region represent the mean of at least two determinations
from separate sections for each of three to four animals.
4.3. [125I]-para-iodoclonidine autoradiography
Sections from the same regions as those described for [3H]
RX821002 autoradiography were used. Sections were incu-
bated in 50 mM Tris–HCl, 120 mM sucrose, pH 7.4, with
50 pM [125I]para-iodoclonidine (PIC) as ligand. Non-specific
binding was determined by addition of 10 μM rauwolscine.
Sections were incubated for 3 h at room temperature in a
horizontal slide mailer with 5 slides/9 ml incubation buffer.
For studies with [125I]PIC, mailers were placed on a shaking
water bath platform, and every 15 min the mailers were
gently inverted three times to ensure homogenous dis-
tribution of the radioligand. After incubation sections were
washed two times for 5 min in ice-cold 50 mM Tris–HCl, pH
7.4, briefly dipped in ice-cold distilled water and rapidly
dried under a stream of cool air. Sections were apposed to
Biomax MR film (Eastman Kodak Co., Rochester, NY) for
48 h. Films were developed by standard procedures and
analyzed using the MCID system, the mouse brain atlas
and commercial tritium standards (American Radiochemi-
cals, St. Louis, MO) that were individually calibrated to 125I-
tissue standards (Miller and Zahniser, 1987).
4.4. α2-AR agonist-stimulated GTPγS autoradiography
Linkage of α2-AR to G proteins was measured using the
agonist-stimulated [35S]GTPγS binding assay (Sim et al., 1995),
as optimized for α2-AR (Happe et al., 2001). Slide mounted
16 μm tissue sections from the same regions as those
described for [3H]RX821002 autoradiography were hydrated
in assay buffer (50mM glycylglycine, 3 mMMgCl2, 1 mM EGTA,
100 mM NaCl, pH 7.5) at room temperature for 10 min. This
was followed by incubation in assay buffer plus 2 mM GDP for
30 min. α2-AR were stimulated by incubation with 100 μM
epinephrine for 2 h in assay buffer with 0.1 nM [35S]GTPγS,
2 mM GDP and 0.2 mM DTT. Addition of 10 μM RX821002, a
specific α2-AR antagonist with similar affinity for all three
receptor subtypes, was used to determine non-specific bind-
ing of [35S]GTPγS. Sections were washed 2×5 min in ice-cold
50 mM glycylglycine, 0.2 mM DTT, pH 7.5; rinsed briefly in ice-
cold distilled water; dried under a stream of cool air; and
apposed to βmax Hyperfilm (Amersham) for three days. Films
were developed by standard procedures and analyzed using
the MCID system, the mouse brain atlas and commercial
tritium standards (American Radiochemicals, St. Louis, MO)
that were individually calibrated in this lab to [35S]-tissue
standards (Miller and Zahniser, 1987). All data for each region
represent the mean of at least two determinations for each of
three to four animals.
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4.5. [3H]Prazosin autoradiography
Autoradiographic studies of α1-AR used procedures as pre-
viously described (Szot et al., 2005). Briefly, tissue sections
16 μm thick were thaw-mounted onto Superfrost Plus slides
and stored at −80 °C. Slides were thawed at room temperature
for 10 min and then 400 μl/slide of incubation buffer (∼0.2 nM
[3H]prazosin in 50 mM Tris buffer, 1 mM EDTA, pH 7.4) was
placed over the tissue. Non-specific bindingwas defined in the
presence of 10 μM phentolamine. Slides were incubated for
40 min at room temperature, washed twice for 2 min in ice-
cold 50 mM Tris buffer, pH 7.4, dipped in ice-cold distilled
water to remove salts and then rapidly dried under a stream of
cool air. Slides were apposed to Biomax MR film (Eastman
Kodak Co.) for 8 weeks. Films were developed by standard
procedures and the resulting images were analyzed using the
MCID system, the mouse brain atlas and commercial tritium
standards. All data for each region represent the mean of at
least three determinations for each of the eight Dbh−/− and
Dbh+/− animals.
4.6. [125I]-Iodo-pindolol autoradiography
Autoradiographic studies of β-AR were carried out by incubating
16 μm slide-mounted horizontal tissue sections in 50 mM Tris,
pH7.4with 50 pM [125I]-iodo-pindolol for 1 h at room temperature.
Non-specific binding was defined by inclusion of 100 μM iso-
proterenol. Following incubation, slideswerewashed 3 × 5min in
ice-cold buffer and a quick rinse in ice-cold distilled water.
Sections were dried under a stream of cool air and apposed to
BioMax film (Kodak) for 24 h. Films were developed by standard
procedures and analyzed using the MCID system, the mouse
brain atlas and commercial tritium standards (American Radio-
chemicals, St. Louis,MO) thatwere individually calibrated to [125I]-
tissue standards. All data for each region represent themeanof at
least two determinations for each of three to four animals.
4.7. Statistics
Data from receptor autoradiography experiments comparing
Dbh+/− and Dbh−/− mice were analyzed with Students two-
tailed t test. Epinephrine-stimulated [35S]GTPγS binding data
were analyzed by one-way ANOVA with the Tukey multiple
comparison post hoc test.
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